Paper890697
Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma.
Malkasian GD and 3 others. Cancer Treat Rep, 1977. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma. Papers, record 890697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/890697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Medroxyprogesterone | Major topic |
| Ovarian Neoplasms | Major topic |
| Female | |
| Humans | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Recurrence |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7272193 | British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7272193 | PubMed |
| 6791675 | In vitro sensitivity of human ovarian tumours to chemotherapeutic agents. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6791675 | PubMed |
| 6699852 | Optimal chemotherapy for ovarian carcinoma: discussion paper. | J R Soc Med | 1984 | https://conductscience.org/library/papers/6699852 | PubMed |
| 6371015 | Developing new drugs for ovarian cancer: a challenging task in a changing reality. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6371015 | PubMed |
| 6223801 | Long acting contraceptives. Present status. | Drugs | 1983 | https://conductscience.org/library/papers/6223801 | PubMed |
| 3543533 | The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer. | Med Oncol Tumor Pharmacother | 1986 | https://conductscience.org/library/papers/3543533 | PubMed |
| 2933176 | In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/2933176 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/890697
GET https://conductscience.org/api/papers/v1/890697/authors